Johnson & Johnson Q3 Profit Plunges, Lifts FY26 Outlook; Stock Drops
· rttnews.com
Drug major Johnson & Johnson on Tuesday reported sharply lower third-quarter profit on special charges, despite sales growth. Further, the firm raised its fiscal 2026 outlook again and announced a quarterly dividend.
Drug major Johnson & Johnson on Tuesday reported sharply lower third-quarter profit mainly on special charge related to proposed talc litigation, despite sales ...